secwatch / observer
8-K filed December 1, 2025, 6:59 PM ET ticker AVR CIK 0002011514
other material confidence medium sentiment neutral materiality 0.30

Anteris Technologies not renewing supply agreement with 4C Medical for ADAPT tissue

Anteris Technologies Global Corp.

item 1.02

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Anteris Technologies Global Corp. terminated Second Amended and Restated Supply and License Agreement, as amended with 4C Medical Technologies, Inc. (effective 2025-11-26).

Action
termination
Agreement
supply
Counterparty
4C Medical Technologies, Inc.
Effective
2025-11-26
Exact text from the filing
On November 26, 2025, Anteris Technologies Global Corp. (the “Company”) notified 4C Medical Technologies, Inc. (“4C”) that it was not renewing the Second Amended and Restated Supply and License Agreement, as amended (the “Supply Agreement”), between the Company and 4C, which provided for the supply by the Company to 4C of ADAPT ® tissue used in 4C’s production of medical devices related to transcatheter mitral valve and tricuspid valve regurgitation therapy and granted a limited license to the Company’s related sterilization methods in connection with use of ADAPT ® tissue by 4C in its production of medical devices.
View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

Anteris Technologies Global Corp. filing history →

Source: SEC EDGAR
accession 0001140361-25-043801
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.